Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Japanese Firm Mitsui Invests In China's Hutchison MediPharma; First Step Toward An IPO?

Nov 09 2010

• By PharmAsia News

Related Content

Chi-Med Expected To Double Revenue By 2015, Backed By Urbanization, Healthcare Reform And TCM Performance in China

Aug 06 2010

Hutchison Medipharma Initiates Phase I Trials Of Cancer-fighting Candidate Sulfatinib In China

May 07 2010

Singapore's S*BIO Initiates Phase II Trials In Canada; Picks Up New Investor

Oct 13 2010

Japan's Mitsui Acquires Stake In India's Arch Pharma For Direct Presence In The "Global Factory"

Sep 23 2010

Shanghai's Hutchison MediPharma Could Close Licensing Deal On Innovative New Crohn's Disease Treatment; Spin-off Likely

Jul 28 2010

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window